Compare Jaya Konstruksi Manggala Pratama Tbk (JKON) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Jaya Konstruksi Manggala Pratama Tbk vs Organon Pharma Indonesia Tbk. — how do they compare? Jaya Konstruksi Manggala Pratama Tbk trades at Rp85 (market cap 1.42T, 13.59M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Jaya Konstruksi Manggala Pratama Tbk is far larger — about 13.6× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| JKON | SCPI | |
|---|---|---|
Market Cap | 1.42T | 104.4B |
Volume | 13.59M | — |
Lot | 135.93K | — |
Turnover | 1.16B | — |
Average Price | 85.47 | — |
Value | 1.16B | — |
Indicative Equilibrium Price | 85 | — |
Indicative Equilibrium Volume | 383 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Jaya Konstruksi Manggala Pratama Tbk
PT Jaya Konstruksi Manggala Pratama Tbk (the company) was established dated December 23, 1982 based on Notaries Deed No.45 of Hobropoerwanto, SH. The Company’s articles of association has been amended several times, most recently by notarial deed No. 142 of Mr. Aulia Taufani, SH., dated Sep 24, 2007, concerning among others, the change Company’s capital structure and public offering.
Read more on JKON →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
